Sep 1, 2022
Redeye Initiate
Aug 18, 2022
Webcast: 2022 Half Year Report presentation
July 5, 2022
Webcast: GARDskin approved by OECD
May 11, 2022, Stockholm
Redeye Theme: Medtech & Diagnostics
Mar 23, 2022, Zürich
Swiss Nordic Bio
Feb 11, 2022
Conference Call: SenzaGen’s 2021 Year-End Report
2021
Dec 16, 2021
Redeye Investor Forum Online
>
Dec 2, 2021
Västra Hamnen Investerardag
October 28, 2021
Investor Presentation (pdf)
Oct 21, 2021 @ 11.00
The BioStock Life Science Summit
Oct 7, 2021
Vator Healthcare Innovation Summit
Oct 5, 2021
Capital Markets Day
Aug 19, 2021
Conference Call: SenzaGen’s 2021 Half-Year Report
July 29, 2021
Webcast: Positive scientific ESAC opinion on GARDskin
– paving the way for OECD validation and opens new commercial opportunities
May 26, 2021
CEO presentation at BioStock Life Science Spring Summit
May 5, 2021
CEO presentation at SenzaGen’s AGM 2021
March 4, 2021
BioStock Studio: SenzaGen is aiming to increase market activity in 2021
Feb 18, 2021 @ 9:30
Conference Call: SenzaGen’s 2020 Year-End report
Feb 10, 2021
Swiss Nordic Bio
2020
Nov 26, 2020
Redeye Life Science Day
Nov 17, 2020
BioStock Life Science Summit
Conference call: Half-Year Report 2020
2020 Annual General Meeting – CEO presentation
Conference call: Year-End Report 2019.
2019
December
4 december | Göteborg, Vator Securities
3 december | Stockholm, Biostock Live
3 december | Stockholm, Vator Securities
November
28 november | Stockholm, Vator Securities
27 november | Stockholm, Unicorn Summit, Vator Securities
27 november | Stockholm, Småbolagsjakten Live, Laika
25 november | Stockholm, Stora Aktiedagen, Aktiespararna
22 november | Malmö, Vator Securities
September
Telefonkonferensl | 19 september, 2019
VD Axel Sjöblad kommenterar den nya kommersiella organisationen och det nya finansiella målet.
Mars
Vator Securities Unicorn Summit | Stockholm | March 21, 2019 (in English)
